Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 142

1.

Simultaneous leadless pacemaker and subcutaneous implantable cardioverter-defibrillator implantation-When vascular options have run out.

Ng JB, Chua K, Teo WS.

J Arrhythm. 2018 Nov 20;35(1):136-138. doi: 10.1002/joa3.12140. eCollection 2019 Feb.

2.

β-tubulin carboxy-terminal tails exhibit isotype-specific effects on microtubule dynamics in human gene-edited cells.

Parker AL, Teo WS, Pandzic E, Vicente JJ, McCarroll JA, Wordeman L, Kavallaris M.

Life Sci Alliance. 2018;1(2). pii: e201800059. doi: 10.26508/lsa.201800059. Epub 2018 Apr 19.

3.

TIP60 represses activation of endogenous retroviral elements.

Rajagopalan D, Tirado-Magallanes R, Bhatia SS, Teo WS, Sian S, Hora S, Lee KK, Zhang Y, Jadhav SP, Wu Y, Gan YH, Karnani N, Benoukraf T, Jha S.

Nucleic Acids Res. 2018 Oct 12;46(18):9456-9470. doi: 10.1093/nar/gky659.

4.

Identification of an INa-dependent and Ito-mediated proarrhythmic mechanism in cardiomyocytes derived from pluripotent stem cells of a Brugada syndrome patient.

Ma D, Liu Z, Loh LJ, Zhao Y, Li G, Liew R, Islam O, Wu J, Chung YY, Teo WS, Ching CK, Tan BY, Chong D, Ho KL, Lim P, Yong RYY, Panama BK, Kaplan AD, Bett GCL, Ware J, Bezzina CR, Verkerk AO, Cook SA, Rasmusson RL, Wei H.

Sci Rep. 2018 Jul 26;8(1):11246. doi: 10.1038/s41598-018-29574-5.

5.

Synthetic biology toolkits and applications in Saccharomyces cerevisiae.

Chen B, Lee HL, Heng YC, Chua N, Teo WS, Choi WJ, Leong SSJ, Foo JL, Chang MW.

Biotechnol Adv. 2018 Nov 15;36(7):1870-1881. doi: 10.1016/j.biotechadv.2018.07.005. Epub 2018 Jul 18. Review.

PMID:
30031049
6.

A novel three base-pair deletion in domain two of the cardiac sodium channel causes Brugada syndrome.

Tan BY, Wang L, Uttamchandani M, Barajas-Martinez H, Dumaine R, Morin N, Ching CK, Ho KL, Chong DTT, Chow W, Yap EPH, Moochhala S, Hu D, Yong RYY, Teo WS.

J Electrocardiol. 2018 Jul - Aug;51(4):667-673. doi: 10.1016/j.jelectrocard.2018.03.009. Epub 2018 Mar 21.

PMID:
29997009
7.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: What is the best practice?

Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK, Bautista-Vargas WF, Chiang CE, Cuesta A, Dan GA, Frankel DS, Guo Y, Hatala R, Lee YS, Murakawa Y, Pellegrini CN, Pinho C, Milan DJ, Morin DP, Nadalin E, Ntaios G, Prabhu MA, Proietti M, Rivard L, Valentino M, Shantsila A.

J Arrhythm. 2018 Mar 23;34(2):99-123. doi: 10.1002/joa3.12050. eCollection 2018 Apr. No abstract available.

8.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?

Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK.

Heart Rhythm. 2018 Jun;15(6):e37-e60. doi: 10.1016/j.hrthm.2018.03.005. Epub 2018 Mar 18. No abstract available.

PMID:
29563045
9.

European Heart Rhythm Association (EHRA)/Heart Rhythm Society (HRS)/Asia Pacific Heart Rhythm Society (APHRS)/Latin American Heart Rhythm Society (LAHRS) expert consensus on arrhythmias and cognitive function: what is the best practice?

Dagres N, Chao TF, Fenelon G, Aguinaga L, Benhayon D, Benjamin EJ, Bunch TJ, Chen LY, Chen SA, Darrieux F, de Paola A, Fauchier L, Goette A, Kalman J, Kalra L, Kim YH, Lane DA, Lip GYH, Lubitz SA, Márquez MF, Potpara T, Pozzer DL, Ruskin JN, Savelieva I, Teo WS, Tse HF, Verma A, Zhang S, Chung MK; ESC Scientific Document Group.

Europace. 2018 Sep 1;20(9):1399-1421. doi: 10.1093/europace/euy046. No abstract available.

PMID:
29562326
10.

Engineering a riboswitch-based genetic platform for the self-directed evolution of acid-tolerant phenotypes.

Pham HL, Wong A, Chua N, Teo WS, Yew WS, Chang MW.

Nat Commun. 2017 Sep 4;8(1):411. doi: 10.1038/s41467-017-00511-w.

11.

Epicardial ablation utilizing remote magnetic navigation in a patient with Brugada syndrome and inferior early repolarization.

Lim PCY, Nademanee K, Lee ECY, Teo WS.

Pacing Clin Electrophysiol. 2018 Feb;41(2):214-217. doi: 10.1111/pace.13175. Epub 2017 Oct 10.

PMID:
28842979
12.

An Emerging Role for Tubulin Isotypes in Modulating Cancer Biology and Chemotherapy Resistance.

Parker AL, Teo WS, McCarroll JA, Kavallaris M.

Int J Mol Sci. 2017 Jul 4;18(7). pii: E1434. doi: 10.3390/ijms18071434. Review.

13.

Remote magnetic catheter navigation versus conventional ablation in atrial fibrillation ablation: Fluoroscopy reduction.

Lim PCY, Toh JJH, Loh JKXY, Lee ECY, Chong DTT, Tan BY, Ho KL, Ching CK, Teo WS.

J Arrhythm. 2017 Jun;33(3):167-171. doi: 10.1016/j.joa.2016.08.007. Epub 2016 Nov 10.

14.

Recent Progress in Energy-Driven Water Splitting.

Tee SY, Win KY, Teo WS, Koh LD, Liu S, Teng CP, Han MY.

Adv Sci (Weinh). 2017 Jan 13;4(5):1600337. doi: 10.1002/advs.201600337. eCollection 2017 May. Review.

15.

2017 HRS expert consensus statement on magnetic resonance imaging and radiation exposure in patients with cardiovascular implantable electronic devices.

Indik JH, Gimbel JR, Abe H, Alkmim-Teixeira R, Birgersdotter-Green U, Clarke GD, Dickfeld TL, Froelich JW, Grant J, Hayes DL, Heidbuchel H, Idriss SF, Kanal E, Lampert R, Machado CE, Mandrola JM, Nazarian S, Patton KK, Rozner MA, Russo RJ, Shen WK, Shinbane JS, Teo WS, Uribe W, Verma A, Wilkoff BL, Woodard PK.

Heart Rhythm. 2017 Jul;14(7):e97-e153. doi: 10.1016/j.hrthm.2017.04.025. Epub 2017 May 11. Review. No abstract available.

PMID:
28502708
16.

Erratum to '2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing' [Journal of Arrhythmia 32/1 (2016) 1-28].

Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Mark Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S.

J Arrhythm. 2016 Oct;32(5):441-442. Epub 2016 Sep 21.

17.

A Two-Layer Gene Circuit for Decoupling Cell Growth from Metabolite Production.

Lo TM, Chng SH, Teo WS, Cho HS, Chang MW.

Cell Syst. 2016 Aug;3(2):133-143. doi: 10.1016/j.cels.2016.07.012.

18.

Remote monitoring of patients with cardiac implantable electronic devices: a Southeast Asian, single-centre pilot study.

Lim PC, Lee AS, Chua KC, Lim ET, Chong DT, Tan BY, Ho KL, Teo WS, Ching CK.

Singapore Med J. 2016 Jul;57(7):372-7. doi: 10.11622/smedj.2016120.

19.

Stathmin mediates neuroblastoma metastasis in a tubulin-independent manner via RhoA/ROCK signaling and enhanced transendothelial migration.

Fife CM, Sagnella SM, Teo WS, Po'uha ST, Byrne FL, Yeap YY, Ng DC, Davis TP, McCarroll JA, Kavallaris M.

Oncogene. 2017 Jan 26;36(4):501-511. doi: 10.1038/onc.2016.220. Epub 2016 Jun 20.

PMID:
27321182
20.

From matrix nano- and micro-phase tougheners to composite macro-properties.

Kinloch AJ, Taylor AC, Techapaitoon M, Teo WS, Sprenger S.

Philos Trans A Math Phys Eng Sci. 2016 Jul 13;374(2071):20150275. doi: 10.1098/rsta.2015.0275.

21.

Patient barriers to implantable cardioverter defibrillator implantation for the primary prevention of sudden cardiac death in patients with heart failure and reduced ejection fraction.

Chan LL, Lim CP, Aung ST, Quetua P, Ho KL, Chong D, Teo WS, Sim D, Ching CK.

Singapore Med J. 2016 Apr;57(4):182-7. doi: 10.11622/smedj.2016072.

22.

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S.

J Arrhythm. 2016 Feb;32(1):1-28. doi: 10.1016/j.joa.2015.12.001. Epub 2016 Feb 1. No abstract available. Erratum in: J Arrhythm. 2016 Oct;32(5):441-442.

23.

First clinical experience of the safety and feasibility of total subcutaneous implantable defibrillator in an Asian population.

Hai JJ, Lim ET, Chan CP, Chan YS, Chan KK, Chong D, Ho KL, Tan BY, Teo WS, Ching CK, Tse HF.

Europace. 2015 Oct;17 Suppl 2:ii63-8. doi: 10.1093/europace/euv144.

PMID:
26842117
24.

Non-fluoroscopic navigation systems for radiofrequency catheter ablation for supraventricular tachycardia reduce ionising radiation exposure.

See J, Amora JL, Lee S, Lim P, Teo WS, Tan BY, Ho KL, Lee CW, Ching CK.

Singapore Med J. 2016 Jul;57(7):390-5. doi: 10.11622/smedj.2016017. Epub 2016 Jan 25.

25.

Engineering transcription factors to improve tolerance against alkane biofuels in Saccharomyces cerevisiae.

Ling H, Pratomo Juwono NK, Teo WS, Liu R, Leong SS, Chang MW.

Biotechnol Biofuels. 2015 Dec 30;8:231. doi: 10.1186/s13068-015-0411-z. eCollection 2015.

26.

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Mark Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, McGuire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S.

Heart Rhythm. 2016 Feb;13(2):e50-86. doi: 10.1016/j.hrthm.2015.11.018. Epub 2015 Dec 1. No abstract available.

PMID:
26607062
27.

2015 HRS/EHRA/APHRS/SOLAECE expert consensus statement on optimal implantable cardioverter-defibrillator programming and testing.

Wilkoff BL, Fauchier L, Stiles MK, Morillo CA, Al-Khatib SM, Almendral J, Aguinaga L, Berger RD, Cuesta A, Daubert JP, Dubner S, Ellenbogen KA, Estes NA 3rd, Fenelon G, Garcia FC, Gasparini M, Haines DE, Healey JS, Hurtwitz JL, Keegan R, Kolb C, Kuck KH, Marinskis G, Martinelli M, Mcguire M, Molina LG, Okumura K, Proclemer A, Russo AM, Singh JP, Swerdlow CD, Teo WS, Uribe W, Viskin S, Wang CC, Zhang S; Document Reviewers.

Europace. 2016 Feb;18(2):159-83. doi: 10.1093/europace/euv411. Epub 2015 Nov 19. No abstract available. Erratum in: Europace. 2017 Apr 1;19(4):580.

PMID:
26585598
28.

Paroxysmal Supraventricular Tachycardia With Ventriculoatrial Block and QRS Duration Shortening: What Is the Mechanism?

Lim PC, Chong DT, Tan BY, Ho KL, Teo WS, Ching CK.

J Cardiovasc Electrophysiol. 2016 May;27(5):616-7. doi: 10.1111/jce.12878. Epub 2015 Dec 17. No abstract available.

PMID:
26552613
29.

Metabolic engineering of Saccharomyces cerevisiae for production of fatty acid short- and branched-chain alkyl esters biodiesel.

Teo WS, Ling H, Yu AQ, Chang MW.

Biotechnol Biofuels. 2015 Nov 4;8:177. doi: 10.1186/s13068-015-0361-5. eCollection 2015.

30.

Initial experience of subcutaneous implantable cardioverter defibrillators in Singapore: a case series and review of the literature.

Lim TS, Tan BY, Ho KL, Lim CY, Teo WS, Ching CK.

Singapore Med J. 2015 Oct;56(10):580-5. doi: 10.11622/smedj.2015154. Review.

31.

A Brugada syndrome proband with compound heterozygote SCN5A mutations identified from a Chinese family in Singapore.

Tan BY, Yong RY, Barajas-Martinez H, Dumaine R, Chew YX, Wasan PS, Ching CK, Ho KL, Gan LS, Morin N, Chong AP, Yap SH, Neo JL, Yap EP, Moochhala S, Chong DT, Chow W, Seow SC, Hu D, Uttamchandani M, Teo WS.

Europace. 2016 Jun;18(6):897-904. doi: 10.1093/europace/euv058. Epub 2015 Mar 31.

PMID:
25829473
32.

ID4 controls mammary stem cells and marks breast cancers with a stem cell-like phenotype.

Junankar S, Baker LA, Roden DL, Nair R, Elsworth B, Gallego-Ortega D, Lacaze P, Cazet A, Nikolic I, Teo WS, Yang J, McFarland A, Harvey K, Naylor MJ, Lakhani SR, Simpson PT, Raghavendra A, Saunus J, Madore J, Kaplan W, Ormandy C, Millar EK, O'Toole S, Yun K, Swarbrick A.

Nat Commun. 2015 Mar 27;6:6548. doi: 10.1038/ncomms7548.

PMID:
25813983
33.

Bacterial XylRs and synthetic promoters function as genetically encoded xylose biosensors in Saccharomyces cerevisiae.

Teo WS, Chang MW.

Biotechnol J. 2015 Feb;10(2):315-22. doi: 10.1002/biot.201400159. Epub 2014 Aug 7.

PMID:
24975936
34.

ID proteins regulate diverse aspects of cancer progression and provide novel therapeutic opportunities.

Nair R, Teo WS, Mittal V, Swarbrick A.

Mol Ther. 2014 Aug;22(8):1407-1415. doi: 10.1038/mt.2014.83. Epub 2014 May 14. Review.

35.

Economic impact analysis of an end-of-life programme for nursing home residents.

Teo WS, Raj AG, Tan WS, Ng CW, Heng BH, Leong IY.

Palliat Med. 2014 May;28(5):430-7. doi: 10.1177/0269216314526270. Epub 2014 Mar 20.

PMID:
24651709
36.

Pacemaker failure due to loss of fluid seal in a patient with a 5/6mm pacemaker header port and a 5mm unipolar lead.

Lim PC, Tan BY, Ho KL, Ching CK, Teo WS.

Indian Pacing Electrophysiol J. 2013 Nov 15;13(6):217-20. eCollection 2013 Nov.

37.

Coronary sinus ostial atresia and persistent left-sided superior vena cava: clinical significance and strategies for cardiac resynchronization therapy.

Lim PC, Baskaran L, Ho KL, Teo WS, Ching CK.

Int J Angiol. 2013 Sep;22(3):199-202. doi: 10.1055/s-0033-1348882.

38.

New insights into the role of ID proteins in breast cancer metastasis: a MET affair.

Teo WS, Nair R, Swarbrick A.

Breast Cancer Res. 2014 May 15;16(2):305. doi: 10.1186/bcr3654.

39.

Trends amongst implantable cardioverter defibrillator patients in a tertiary cardiac centre in Singapore from 2002 to 2011.

Chong DT, Tan BY, Ho KL, Teo WS, Ching CK.

Ann Acad Med Singapore. 2013 Sep;42(9):480-2. No abstract available.

40.

c-Myc and Her2 cooperate to drive a stem-like phenotype with poor prognosis in breast cancer.

Nair R, Roden DL, Teo WS, McFarland A, Junankar S, Ye S, Nguyen A, Yang J, Nikolic I, Hui M, Morey A, Shah J, Pfefferle AD, Usary J, Selinger C, Baker LA, Armstrong N, Cowley MJ, Naylor MJ, Ormandy CJ, Lakhani SR, Herschkowitz JI, Perou CM, Kaplan W, O'Toole SA, Swarbrick A.

Oncogene. 2014 Jul 24;33(30):3992-4002. doi: 10.1038/onc.2013.368. Epub 2013 Sep 23.

PMID:
24056965
41.

Development and characterization of AND-gate dynamic controllers with a modular synthetic GAL1 core promoter in Saccharomyces cerevisiae.

Teo WS, Chang MW.

Biotechnol Bioeng. 2014 Jan;111(1):144-51. doi: 10.1002/bit.25001. Epub 2013 Aug 12.

PMID:
23860786
42.

Authors' response to the correspondence entitled 'too ill for an implantable cardioverter defibrillator?'.

Chong D, Tan BY, Ho KL, Teo WS, Ching CK.

Europace. 2013 Aug;15(8):1226-7. doi: 10.1093/europace/eut205. Epub 2013 Jun 26. No abstract available.

PMID:
23804015
43.

Forest of gold nanowires: a new type of nanocrystal growth.

He J, Wang Y, Feng Y, Qi X, Zeng Z, Liu Q, Teo WS, Gan CL, Zhang H, Chen H.

ACS Nano. 2013 Mar 26;7(3):2733-40. doi: 10.1021/nn4001885. Epub 2013 Mar 5.

PMID:
23442034
44.

Microbial engineering strategies to improve cell viability for biochemical production.

Lo TM, Teo WS, Ling H, Chen B, Kang A, Chang MW.

Biotechnol Adv. 2013 Nov;31(6):903-14. doi: 10.1016/j.biotechadv.2013.02.001. Epub 2013 Feb 10. Review.

PMID:
23403071
45.

Pneumocystis carinii (jirovecii) pneumonia (PCP): the most common opportunistic infection observed in HIV/AIDS cases at the University Malaya Medical Centre, Kuala Lumpur, Malaysia.

Jamaiah I, Rohela M, Tok EL, Tan CL, Tan WH, Teo WS, Leow HF.

Southeast Asian J Trop Med Public Health. 2012 Jul;43(4):825-31.

PMID:
23077803
46.

Clinical markers of organ dysfunction associated with increased 1-year mortality post-implantable cardioverter defibrillator implantation.

Chong D, Tan BY, Ho KL, Liew R, Teo WS, Ching CK.

Europace. 2013 Apr;15(4):508-14. doi: 10.1093/europace/eus225. Epub 2012 Jul 29.

PMID:
22848076
47.

Fragmented QRS complexes predict right ventricular dysfunction and outflow tract aneurysms in patients with repaired tetralogy of Fallot.

Shanmugam N, Yap J, Tan RS, Le TT, Gao F, Chan JX, Chong D, Ho KL, Tan BY, Ching CK, Teo WS, Tan JL, Liew R.

Int J Cardiol. 2013 Aug 20;167(4):1366-72. doi: 10.1016/j.ijcard.2012.04.004. Epub 2012 Apr 21.

PMID:
22521381
48.

Atrial fibrillation management in Asia: from the Asian expert forum on atrial fibrillation.

Chiang CE, Zhang S, Tse HF, Teo WS, Omar R, Sriratanasathavorn C.

Int J Cardiol. 2013 Mar 20;164(1):21-32. doi: 10.1016/j.ijcard.2011.12.033. Epub 2012 Jan 10. Review.

PMID:
22240753
49.

Economic burden of chronic obstructive pulmonary disease.

Teo WS, Tan WS, Chong WF, Abisheganaden J, Lew YJ, Lim TK, Heng BH.

Respirology. 2012 Jan;17(1):120-6. doi: 10.1111/j.1440-1843.2011.02073.x.

PMID:
21954985
50.

Successful ablation of sinus node reentrant tachycardia using remote magnetic navigation system.

Malik AK, Ching CK, Liew R, Chong DT, Teo WS.

Europace. 2012 Mar;14(3):455-6. doi: 10.1093/europace/eur283. Epub 2011 Sep 4.

PMID:
21893510

Supplemental Content

Support Center